Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...

Understanding epi-transcriptome changes in diffuse midline gliomas H3 K27-altered (DMGs) could provide novel therapeutic options. RNA N6-methyladenosine (m6A) is a key epi-transcriptomic modification ...

Riccardo Balestri, MD, PhD, discusses his research on coexistent psoriasis and atopic dermatitis, also known as PsoDermatitis ...

Psychiatric disorders, such as bipolar disorder (BD), major depressive disorder (MDD), schizophrenia and anxiety disorders, ...

In the field of neuro-oncology, the dual topics of cellular metabolism and the tumor microenvironment (TME) have gained ...

Many aromatic compounds, such as phenols, cresols and styrenes, are toxic to organisms and harmful to the environment. They ...

Scientists profiling small non-coding RNAs in postmortem brain tissue from people with schizophrenia and bipolar disorder ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced an oral presentation at the United States and Canadian Academy of Pathology (USCAP) 115th Annual ...

Abstract: Deciphering cell-type composition is critical for charting single-cell spatial maps and cellular atlases of organisms. Most Spatial Transcriptomics (ST) data lack single-cell resolution, ...

Single-cell sequencing is useful for a number of applications. For example, it can reveal cellular heterogeneity inside complex tissues, such as tumors. It can also provide information about how ...